Literature DB >> 34515878

A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target.

Ji-Li Xu1, Yong Guo2.   

Abstract

BACKGROUND: Pancreatic cancer (PC) is one of the most lethal cancer types with an extremely poor diagnosis and prognosis. This study aimed to comprehensively analyze the relationships between PC and different gene classes.
METHODS: Numerous genes from different categories were selected from the UALCAN database. Expression and survival analysis of these genes were performed via GEPIA, starBase and Kaplan-Meier Plotter tools. The correlations between PC-related genes and frequently mutated genes in PC as well as myeloid-derived suppressor cells (MDSCs) infiltration levels were explored by TIMER tool. The associations between PC-related genes, immune checkpoints and 182 core cancer-intrinsic CTLs-evasion genes were analyzed by R software. Besides, KEGG analysis were performed for the PC-related genes.
RESULTS: 14 genes were identified to be highly expressed in pancreatic cancer and significantly associated with poor prognosis. Besides, high expression of these genes were observed in patients with KRAS or TP53 mutations. Most genes were significantly positively associated with immune checkpoint SIGLEC15, however, showed negative relations to PDCD1, CTLA4, LAG3, TIGIT, PDCD1LG2. In addition, all 14 genes exhibited close relationships with MDSC infiltration levels and various core cancer-intrinsic CTLs-evasion genes, especially DNTTIP1, FADD, ARF6, BCL2L1, CEP55, GALE, PDCD6IP, and RCE1. We also explored the most related pathways with these genes to further reveal the pathogenesis and metastatic mechanisms of PC.
CONCLUSION: Our study analyzed the relationships between 14 PC-related genes and pancreatic cancer from different angles, which may contribute to a better understanding of unsolved mystery in PC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Expression; Immune escape; Pancreatic cancer; Prognosis; SIGLEC15

Mesh:

Substances:

Year:  2021        PMID: 34515878     DOI: 10.1007/s10637-021-01176-5

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  40 in total

1.  Stromal response to Hedgehog signaling restrains pancreatic cancer progression.

Authors:  John J Lee; Rushika M Perera; Huaijun Wang; Dai-Chen Wu; X Shawn Liu; Shiwei Han; Julien Fitamant; Phillip D Jones; Krishna S Ghanta; Sally Kawano; Julia M Nagle; Vikram Deshpande; Yves Boucher; Tomoyo Kato; James K Chen; Jürgen K Willmann; Nabeel Bardeesy; Philip A Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

2.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

Authors:  Andrea H Bild; Guang Yao; Jeffrey T Chang; Quanli Wang; Anil Potti; Dawn Chasse; Mary-Beth Joshi; David Harpole; Johnathan M Lancaster; Andrew Berchuck; John A Olson; Jeffrey R Marks; Holly K Dressman; Mike West; Joseph R Nevins
Journal:  Nature       Date:  2005-11-06       Impact factor: 49.962

Review 3.  Pancreatic cancer.

Authors:  Jorg Kleeff; Murray Korc; Minoti Apte; Carlo La Vecchia; Colin D Johnson; Andrew V Biankin; Rachel E Neale; Margaret Tempero; David A Tuveson; Ralph H Hruban; John P Neoptolemos
Journal:  Nat Rev Dis Primers       Date:  2016-04-21       Impact factor: 52.329

4.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

Review 5.  Phosphoproteomics in cancer.

Authors:  H C Harsha; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2010-09-26       Impact factor: 6.603

6.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.

Authors:  Sarah P Thayer; Marina Pasca di Magliano; Patrick W Heiser; Corinne M Nielsen; Drucilla J Roberts; Gregory Y Lauwers; Yan Ping Qi; Stephan Gysin; Carlos Fernández-del Castillo; Vijay Yajnik; Bozena Antoniu; Martin McMahon; Andrew L Warshaw; Matthias Hebrok
Journal:  Nature       Date:  2003-09-14       Impact factor: 49.962

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 8.  TAMing pancreatic cancer: combat with a double edged sword.

Authors:  Manendra Babu Lankadasari; Pramiti Mukhopadhyay; Sabira Mohammed; Kuzhuvelil B Harikumar
Journal:  Mol Cancer       Date:  2019-03-30       Impact factor: 27.401

9.  MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells.

Authors:  Chumei Huang; Yaqing Li; Yubo Guo; Zuoquan Zhang; Guoda Lian; Yinting Chen; Jian Li; Yonghui Su; Jiajia Li; Kege Yang; Shaojie Chen; Hong Su; Kaihong Huang; Linjuan Zeng
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

10.  Reversal of homocysteine-induced neurotoxicity in rat hippocampal neurons by astaxanthin: evidences for mitochondrial dysfunction and signaling crosstalk.

Authors:  Xian-Jun Wang; Wang Chen; Xiao-Ting Fu; Jin-Kui Ma; Mei-Hong Wang; Ya-Jun Hou; Da-Chen Tian; Xiao-Yan Fu; Cun-Dong Fan
Journal:  Cell Death Discov       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.